Bladder Cancer Clinical Trial
Determinants of Bladder Cancer Recurrence Study (The DETER Study)
The purpose of this study is to learn how different lifestyle factors, such as cigarette smoking and body weight, change after a diagnosis of bladder cancer, and how they influence who gets a bladder cancer recurrence and who does not.
Patients ≥18 years old AND
Histologically-confirmed non-muscle invasive bladder cancer (NMIBC)
Patients are ineligible for the study if they have/had:
Histologically-confirmed NMIBC diagnosed >36 months prior to enrollment
Cystectomy prior to enrollment
Any condition, which in the opinion of the primary MSK clinician or investigators precludes their ability to provide informed consent or comply with study procedures
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 3 Locations for this study
Basking Ridge New Jersey, , United States
Commack New York, 11725, United States
Harrison New York, 10604, United States
New York New York, 10065, United States
How clear is this clinincal trial information?
Introducing, the Journey Bar
Use this bar to access information about the steps in your cancer journey.